Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Yngvi Bio ApS
APS
Active
Advertising protection
CVR 45351335
Ole Maaløes Vej 3, 2200
København N
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2025 · 1 year old
4 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Yngvi Bio ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
-1M
-1M
-1M
-1M
2025
EBITDA
DKK millions
0M
-1M
-1M
-2M
-2M
-2M
2025
Income statement
DKK thousands
Item
2025
Gross profit
-1.054
Staff expenses
-1.077
EBITDA
-2.131
Depreciation & amort.
-0
EBIT
-2.131
Net financials
-168
Profit before tax
-2.298
Tax
-272
Net profit
-2.026
Balance sheet
DKK thousands
Item
2025
Total assets
2.973
Equity
-1.986
Long-term debt
4.807
Short-term debt
153
Total debt
4.960
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-213088000.0%
This company
2025
2025
Equity ratio
-66.8%
This company
38.2%
Market median
275% below market
2025
2025
Return on equity
-202619000.0%
This company
18.4%
Market median
1101190317% below market
2025
2025
Net profit margin (of gross profit)
-202619000.0%
This company
2025
2025
Asset turnover (of gross profit)
-0.35×
This company
2025
2025
Debt / equity
2.50×
This company
0.62×
Market median
303% above market
2025
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-23 – 2025-12-31
View
PDF
More on Yngvi Bio ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
